These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25878720)

  • 1. Cytochrome P450 2B6 genetic variants are associated with plasma nevirapine levels and clinical response in HIV-1 infected Kenyan women: a prospective cohort study.
    Oluka MN; Okalebo FA; Guantai AN; McClelland RS; Graham SM
    AIDS Res Ther; 2015; 12():10. PubMed ID: 25878720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of CYP2B6 and CYP1A2 Genetic Variation on Nevirapine Plasma Concentration and Pharmacodynamics as Measured by CD4 Cell Count in Zimbabwean HIV-Infected Patients.
    Mhandire D; Lacerda M; Castel S; Mhandire K; Zhou D; Swart M; Shamu T; Smith P; Musingwini T; Wiesner L; Stray-Pedersen B; Dandara C
    OMICS; 2015 Sep; 19(9):553-62. PubMed ID: 26348712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children.
    Saitoh A; Sarles E; Capparelli E; Aweeka F; Kovacs A; Burchett SK; Wiznia A; Nachman S; Fenton T; Spector SA
    AIDS; 2007 Oct; 21(16):2191-9. PubMed ID: 18090046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cytochrome P450 2B6 and constitutive androstane receptor genetic variation on Efavirenz plasma concentrations among HIV patients in Kenya.
    Ngayo MO; Oluka M; Kwena ZA; Bulimo WD; Okalebo FA
    PLoS One; 2022; 17(3):e0260872. PubMed ID: 35235559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of CYP2B6 516G>T polymorphism in patients with ARV-associated hepatotoxicity.
    Singh H; Lata S; Dhole TN; Gangakhedkar RR
    Mol Genet Genomic Med; 2019 Apr; 7(4):e00598. PubMed ID: 30864294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmission.
    Vardhanabhuti S; Acosta EP; Ribaudo HJ; Severe P; Lalloo U; Kumarasamy N; Taulo F; Kabanda J; Oneko O; Ive P; Sambarey P; Chan ES; Hitti J; Hong F; McMahon D; Haas DW;
    J Infect Dis; 2013 Aug; 208(4):662-71. PubMed ID: 23687222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda.
    Penzak SR; Kabuye G; Mugyenyi P; Mbamanya F; Natarajan V; Alfaro RM; Kityo C; Formentini E; Masur H
    HIV Med; 2007 Mar; 8(2):86-91. PubMed ID: 17352764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 2B6 516G-->T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population.
    Mahungu T; Smith C; Turner F; Egan D; Youle M; Johnson M; Khoo S; Back Dj; Owen A
    HIV Med; 2009 May; 10(5):310-7. PubMed ID: 19228205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations.
    Carr DF; Chaponda M; Cornejo Castro EM; Jorgensen AL; Khoo S; Van Oosterhout JJ; Dandara C; Kampira E; Ssali F; Munderi P; Lalloo DG; Heyderman RS; Pirmohamed M
    J Antimicrob Chemother; 2014 Dec; 69(12):3329-34. PubMed ID: 25147095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi.
    Dickinson L; Chaponda M; Carr DF; van Oosterhout JJ; Kumwenda J; Lalloo DG; Pirmohamed M; Heyderman RS; Khoo SH
    Antimicrob Agents Chemother; 2014; 58(2):706-12. PubMed ID: 24217698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults.
    Uttayamakul S; Likanonsakul S; Manosuthi W; Wichukchinda N; Kalambaheti T; Nakayama EE; Shioda T; Khusmith S
    AIDS Res Ther; 2010 Mar; 7():8. PubMed ID: 20338069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between ABCB1, CYP2A6, CYP2B6, CYP2D6, and CYP3A5 alleles in relation to efavirenz and nevirapine pharmacokinetics in HIV-infected individuals.
    Heil SG; van der Ende ME; Schenk PW; van der Heiden I; Lindemans J; Burger D; van Schaik RH
    Ther Drug Monit; 2012 Apr; 34(2):153-9. PubMed ID: 22354160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trough plasma nevirapine levels, immunologic and virologic responses in composite CYP2B6*6/*18 HIV-infected adult Nigerian patients.
    Abdullahi ST; Soyinka JO; Bolarinwa RA; Olarewaju OJ; Salami AK; Bakare-Odunola MT
    Basic Clin Pharmacol Toxicol; 2022 Jul; 131(1):45-52. PubMed ID: 35484635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of
    Maseng MJ; Tawe L; Thami PK; Seatla KK; Moyo S; Martinelli A; Kasvosve I; Novitsky V; Essex M; Russo G; Gaseitsiwe S; Paganotti GM
    Pharmgenomics Pers Med; 2021; 14():335-347. PubMed ID: 33758532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele and Genotype Frequencies of Cytochrome P450 2B6 516G>T Single Nucleotide Polymorphism in HIV-Negative and HIV-Infected Adult Nigerian Populations.
    Saʼad Toyin A; Julius Olugbenga S; Rahman Ayodele B; Olusola Joseph O; Taibat Moji BO
    Am J Ther; 2016; 23(6):e1715-e1719. PubMed ID: 26938766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic-pharmacogenetic study of nevirapine in HIV-infected Cambodian patients.
    Chou M; Bertrand J; Segeral O; Verstuyft C; Borand L; Comets E; Le Tiec C; Becquemont L; Ouk V; Mentre F; Taburet AM
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4432-9. PubMed ID: 20696882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of genetic polymorphisms in cytochrome P450 and effects of tuberculosis co-treatment on the predictive value of CYP2B6 SNPs and on efavirenz plasma levels in adult HIV patients.
    Bienvenu E; Swart M; Dandara C; Ashton M
    Antiviral Res; 2014 Feb; 102():44-53. PubMed ID: 24316028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children.
    Bienczak A; Cook A; Wiesner L; Olagunju A; Mulenga V; Kityo C; Kekitiinwa A; Owen A; Walker AS; Gibb DM; McIlleron H; Burger D; Denti P
    Br J Clin Pharmacol; 2016 Jul; 82(1):185-98. PubMed ID: 26991336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women.
    Chantarangsu S; Cressey TR; Mahasirimongkol S; Capparelli E; Tawon Y; Ngo-Giang-Huong N; Jourdain G; Lallemant M; Chantratita W
    J Antimicrob Chemother; 2009 Dec; 64(6):1265-73. PubMed ID: 19812066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African children.
    Bienczak A; Cook A; Wiesner L; Mulenga V; Kityo C; Kekitiinwa A; Walker AS; Owen A; Gibb DM; Burger D; McIlleron H; Denti P
    J Antimicrob Chemother; 2017 Jan; 72(1):190-199. PubMed ID: 27707991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.